Evidence mapPaperPMID 41496830Full record

ArticleRSC advances2026

Zinc molybdenum thiovanadate nanoparticles: synthesis, characterization, and antibacterial activity.

Fatimah Alahmari

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Fatimah AlahmariDepartment of Nanomedicine Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University P. O. Box 1982 31441 Dammam Saudi Arabia fsalahmari@iau.edu.sa.ORCID https://orcid.org/0000-0002-6527-3961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection control is a key point for maintaining and developing the healthcare sector. Nanosized metal derivatives have attracted significant interest for preventing infections caused by various bacteria and fungi. This study reports the synthesis of new sulfide nanoparticles containing bioactive Zn, Mo, and V in one structure. Powder X-ray diffraction (PXRD) analysis was used to determine the structure, phase purity, and crystallite size of the ZnMoVS

Identifiers

PMID41496830
PMCPMC12766378

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.